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Abstract
Background: Protein kinases are major components of signal transduction pathways in multiple cellular processes. Kinases
directly interact with and phosphorylate downstream substrates, thus modulating their functions. Despite the importance
of identifying substrates in order to more fully understand the signaling network of respective kinases, efficient methods to
search for substrates remain poorly explored.
Methodology/Principal Findings: We combined mass spectrometry and affinity column chromatography of the catalytic
domain of protein kinases to screen potential substrates. Using the active catalytic fragment of Rho-kinase/ROCK/ROK as the
model bait, we obtained about 300 interacting proteins from the rat brain cytosol fraction, which included the proteins
previously reported as Rho-kinase substrates. Several novel interacting proteins, including doublecortin, were
phosphorylated by Rho-kinase both in vitro and in vivo.
Conclusions/Significance: This method would enable identification of novel specific substrates for kinases such as Rho-
kinase with high sensitivity.
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Introduction
Protein phosphorylation is one of the most ubiquitous and
essential mechanisms mediating intracellular signal transduction in
various cellular processes. About 500 protein kinases are encoded
in the human genome, where these are mainly divided into two
groups, Ser/Thr protein kinases and Tyr protein kinases. Kinases
recognize and phosphorylate their specific substrates and modu-
late their functions. In the cell, numerous proteins are continu-
ously and dynamically phosphorylated and dephosphorylated
under the control of complex signaling networks. Comprehensive
screening of substrates for kinases is necessary to increase
understanding of the signaling networks in which protein kinases
participate. However, it remains difficult to efficiently screen the
physiological substrates of protein kinases.
In vitro kinase assays have been used to identify potential
substrates for specific kinases for many years. As an extension of
this method, genome-wide screening of substrates for 87 yeast
protein kinases has been performed using protein microarrays
containing 4,400 yeast proteins [1]. However, this method requires
a large number of recombinant proteins, and the native
conformation of substrates may be lost on the plates. One of the
recent phosphoproteomic strategies is the semi-quantitative liquid
chromatography tandem mass spectrometry (LC-MS/MS) ap-
proach combined with phosphopeptide enrichment, in which
proteins or peptides from cells treated with agonists and protein
kinase inhibitors are labeled with stable isotope or isobaric reagent
iTRAQ ([2,3] for reviews). Two-dimensional fluorescence differ-
ence gel electrophoresis (2D-DIGE) has also been used to identify
potential substrates for ERK from the cells treated with a MEK
inhibitor [4]. Both methods require specific antagonists, agonists
and/or RNA interference to identify the responsible kinases. Thus,
screening of direct substrates for specific kinases is still laborious
and difficult.
Protein kinases share common catalytic domain structures
composed of a small N-terminal lobe and a large C-terminal lobe.
The cleft between these lobes is the active center that binds to both
ATP and the substrate. In spite of highly analogous structures,
protein kinases exhibit striking substrate specificity partly due to
their surface charge and hydrophobicity [5]. In addition to the
active center, several kinases, such as MAPK, GSK3 and PDK1,
have been reported to associate with substrates through extra
docking sites, which may confer substrate specificity and facilitate
phosphorylation efficiency [6]. Nevertheless, the interaction
between protein kinases and substrates is transient and not very
stable, such that utilizing the interaction to identify substrates has
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recent improvement in the sensitivity of mass spectrometry is
expected to make it possible to detect substrate proteins weakly
associated with the catalytic domain of protein kinases.
Here, we developed a method combining affinity column
chromatography, using the active catalytic fragment of protein
kinase as a bait, and shotgun LC-MS/MS to efficiently screen the
kinase substrates. We employed Rho-kinase/ROCK/ROK, a
Ser/Thr protein kinase belonging to the AGC family of kinases, as
a model protein kinase. Rho-kinase is an effector of small GTPase
Rho and is implicated in various cellular functions, including cell
migration, cell adhesion, smooth muscle contraction, cytokinesis
and neurite retraction [7,8]. Here, we describe our discovery of
more than a hundred proteins that specifically interacted with
Rho-kinase, some of which functioned as Rho-kinase substrates.
Results
Affinity column chromatography of Rho-kinase
To screen potential substrates of Rho-kinase, we examined
whether the active catalytic fragment of Rho-kinase (Rho-kinase-
cat) interacts with its substrates by affinity column chromatogra-
phy. Rat brain cytosol or peripheral membrane (P2) fractions
concentrated by ammonium sulfate precipitation were loaded onto
a glutathione-sepharose affinity column on which GST, GST-
Rho-kinase-cat, or GST-Rho-kinase-cat-KD, a kinase-deficient
mutant of Rho-kinase, was immobilized (Figure 1A, B). GST-
PKN-cat, another Rho effector belonging to the PKC subfamily in
the AGC family of kinases, was also subjected to affinity column
chromatography. The proteins bound to the affinity columns were
then eluted by addition of 50 mM and 1 M NaCl, and then
10 mM glutathione. Numerous proteins were detected in the
eluates from the GST-Rho-kinase-cat, GST-Rho-kinase-cat-KD
and GST-PKN-cat columns (Figure 1C, D). The apparent pattern
of eluted proteins in the eluate from the GST-Rho-kinase-cat
column was similar to that from the GST-Rho-kinase-cat-KD
column, and different from that off the GST-PKN-cat column.
Identification and phosphorylation of Rho-kinase-
interacting proteins
The proteins eluted off the affinity columns with 1 M NaCl
were subjected to reduction, alkylation, demineralization, concen-
tration, and then digestion with trypsin. The peptide mixtures
were subjected to reverse phase HPLC and subsequent mass
spectrometry. Measurements of peptide masses by LC-MS/MS
Figure 1. Isolation of interacting proteins for the catalytic domain of Rho-kinase. (A) Domain structure of Rho-kinase and the constructs
used for affinity column chromatography. (B) Strategy for isolation of protein kinase substrates. (C, D) Isolation of Rho-kinase-cat-interacting proteins
from rat brain cytosol (C) and P2 (D) fractions. The cytosolic or P2 fraction of rat brain lysate was loaded onto a Glutathione-Sepharose column coated
with either GST, GST-Rho-kinase-cat, GST-Rho-kinase-cat-KD or GST-PKN-cat. The bound proteins were eluted by addition of 1 M NaCl after washing
with 50 mM NaCl. The eluates were analyze by SDS-PAGE, and visualized by silver staining. Arrowheads indicate the GST-tagged proteins used as
baits.
doi:10.1371/journal.pone.0008704.g001
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identified representative Rho-kinase-cat-interacting proteins from
the rat brain cytosol and P2 fractions are shown in Supplementary
Table, which lists 297 and 313 identified proteins. Under the same
conditions, 60, 214, and 348 proteins from the cytosol fraction,
and 101, 328, and 416 proteins from the P2 fraction were
identified in the eluates from the GST, GST-Rho-kinase-cat-KD,
and GST-PKN-cat affinity columns, respectively (Figure 2A).
Several known substrates, such as MYPT1 and CRMP-2
(DPYL2), were detected in the eluate from the GST-Rho-kinase-
cat column (Figure 2B). MYPT1 was specifically detected from the
GST-Rho-kinase-cat and -cat-KD columns, but was barely
observable from the GST-PKN-cat column, whereas CRMP-2
was also detected in eluate off the GST-PKN-cat column with
higher scores (Figure 2B). The numbers of proteins specifically or
commonly detected off of GST-Rho-kinase-cat and -PKN-cat
columns are shown in Figure 2C. To confirm whether the
previously identified substrates exist in these samples, immunoblot
analysis was performed. The bands recognized by anti-CRMP-2
Ab were detected in the 1M NaCl eluates from the GST-Rho-
kinase-cat, -cat-KD and -PKN-cat columns and were in good
agreement with their protein scores from LC-MS/MS analysis
(Figure S1). Mascot scores are calculated for every peptide and
protein, and indicate the absolute probability that observed match
is a random event, demonstrating that high score is a low
possibility. The more number peptides are identified, the higher
score of the protein. Although it is not a quantitative evaluation,
protein scores are expected to partly reflect the abundance of
proteins, which was consistent with our immunoblot data.
In addition to the known substrates, a number of proteins
specifically or preferentially associated with Rho-kinase
(Figure 3A). Of note, Rho-kinase-cat-interacting proteins includ-
ed transmembrane proteins, such as amyloid precursor protein
(APP) and the receptor-type tyrosine-protein phosphatase delta
(PTPRD) (Figure 3A). This may be explained by the brain extract
including the microsomal fraction. Among novel Rho-kinase-cat-
interacting proteins, APP, AP180, and Doublecortin (DCX) were
subjected to further analyses as candidates of novel substrates
because they represent transmembrane, endocytic and cytoskel-
etal proteins. APP and AP180 were detected in eluates from the
Figure 2. Identification of Rho-kinase-cat-interacting proteins. (A) Total numbers of hit proteins detected in eluates off each affinity column.
(B) Known substrates for Rho-kinase detected in eluates off each affinity column. The numbers indicate protein scores by Mascot analysis. (C) The
numbers of proteins specifically or commonly detected in GST-Rho-kinase-cat and GST-PKN-cat columns are shown. These results are representatives
of at least three independent experiments.
doi:10.1371/journal.pone.0008704.g002
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from the PKN-cat column, whereas DCX was detected in eluates
from the PKN-cat column, with higher scores than the Rho-
kinase-cat columns (Figure 3A). The elution profiles of AP180
and DCX were also examined by immunoblot analysis, which
demonstrated that the profiles were similar to LC-MS/MS scores
(Figure 3B). To investigate whether these proteins are phosphor-
ylated by Rho-kinase, an in vitro phosphorylation assay was
performed. The cytoplasmic region of APP and GST-AP180
were efficiently phosphorylated by Rho-kinase-cat, and weakly
by PKN-cat (Figure 3C, D). GST-DCX was efficiently phos-
phorylated by both Rho-kinase-cat and PKN-cat. Phosphoryla-
tion levels of GST-DCX by PKN-cat were slightly higher than
those by Rho-kinase-cat (Figure 3D). We also confirmed that
CRMP-2 was phosphorylated by PKN-cat (data not shown).
Phosphorylation efficacy of these proteins appeared to correlate
with their affinities for the respective catalytic fragments of Rho-
kinase and PKN. These results suggest that this method, based on
kinase-substrate interaction, is effective for identifying new
substrates.
Phosphorylation of DCX by Rho-kinase
To examine whether this method is useful for screening novel
substrates, not only in vitro but also in vivo, we focused on DCX,
because the role of DCX and its phosphorylation by PKA and
Cdk5 has been elucidated [9,10]. DCX binds and stabilizes
microtubules in young neurons, and Rho regulates the reorgani-
zation of actin and microtubules [11]. We narrowed down the
phosphorylation sites in DCX by making four fragments of DCX,
GST-DCX-N1 (1–67 aa), -N2 (67–165 aa), -C1 (160–278 aa) and
-C2 (274–365 aa) (Figure 4A). Among these fragments, Rho-
kinase most heavily phosphorylated DCX-N1, indicating that the
N1 region includes the major phosphorylation site. PKN also
phosphorylated DCX-N1 efficiently, and -C1 and -C2 moderately
(Figure 4B). R/KXXS/T or R/KXS/T (X is any amino acid) are
known as the consensus phosphorylation sites of Rho-kinase. The
potential phosphorylation sites in DCX-N1 are Thr-14, Ser-15,
Ser-21, Thr-40 and Thr-42 (Figure 4C). To determine the possible
Rho-kinase phosphorylation sites in DCX, we produced GST-
DCX-S14A, -S15A, -T21A, -T40A and -T42A, in which serine or
threonine was substituted with alanine, and examined phosphor-
Figure 3. Identification of novel substrates for Rho-kinase. (A) Protein scores of APP, AP180, and DCX in eluates off each affinity column. (B)
Immunoblot analysis of eluates with anti-AP180 and -DCX Abs. Eluates off affinity columns with 50 mM and 1 M NaCl were subjected to immunoblot
analysis with anti-AP180 and -DCX Abs. AP180 was detected in both 50 mM and 1 M NaCl eluates off the Rho-kinase-cat column, but was barely
detectable in eluates off the PKN-cat column. On the contrary, DCX was strongly detected in eluates off the PKN-cat column, and moderately off the
Rho-kinase-cat column. Arrows indicate the positions of AP180 and DCX. The lower bands are supposed to be degradation products or splice
variants. (C) The APP cytoplasmic peptide was incubated with GST-Rho-kinase-cat or GST-PKN-cat in the presence of 100 mM[ c-
32P] ATP for 1 h at
30uC. The reaction mixtures were applied to P81 paper and subjected to scintillation counting. (D) GST-AP180 (left) or GST-DCX (right) was incubated
with GST-Rho-kinase-cat or GST-PKN-cat in the presence of 100 mM[ c-
32P] ATP for 1 h at 30uC. The reaction mixtures were subjected to SDS-PAGE,
and phosphorylated proteins were imaged by autoradiography. Arrowheads and arrows indicate substrates and autophosphorylation of Rho-kinase,
respectively. These results are representatives of at least three independent experiments.
doi:10.1371/journal.pone.0008704.g003
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Rho-kinase was much lower than that of GST-DCX-wild type
(WT) (Figure 4D). The phosphorylation level of DCX-T40A was
slightly lower (Figure 4D), and other mutations of GST-DCX did
not affect phosphorylation (date not shown), indicating that Thr-
42 is the major phosphorylation site. The phosphorylation level of
GST-DCX-T40A/T42A by Rho-kinase was less than that of
GST-DCX-T42A (Figure 4D), suggesting that Thr-40 is a minor
phosphorylation site. DCX is phosphorylated at Ser-47 by PKA
and at Ser-297 by Cdk5 [9,10]. We also confirmed that Rho-
kinase did not phosphorylate DCX at Ser-47 or at Ser-297 (data
not shown).
To monitor DCX phosphorylation by Rho-kinase, the poly-
clonal antibody that specifically recognizes DCX phosphorylated
at Thr-42 (anti-pT42 Ab) was produced using a phosphopeptide
corresponding to amino acids 37–47 of DCX, in which Thr-42 is
phosphorylated as an antigen. The immunoblot analysis revealed
that anti-pT42 Ab recognized the phosphorylated DCX in a dose-
dependent manner, but did not react with the non-phosphorylated
form or T42A mutant (Figure 5A).
To examine whether Rho-kinase phosphorylates DCX in intact
cells, GFP-DCX was transfected into COS7 cells, because DCX is
specifically expressed in young neurons but not in most non-
neuronal cell lines, including COS7 cells. The immunoblot
analysis showed that phosphorylation of GFP-DCX at Thr-42 is
undetectable under the conditions in which GFP-DCX was well
expressed (Figure 5B). To induce DCX phosphorylation in COS7
cells, the cells were treated with calyculin A (CLA), a PP1/PP2A-
type phosphatase inhibitor [12]. CLA enhanced phosphorylation
of GFP-DCX, and Y-27632, a specific inhibitor of Rho-kinase,
inhibited CLA-induced phosphorylation, suggesting that Rho-
kinase can phosphorylate GFP-DCX at Thr-42 in COS7 cells
under certain conditions. GFP-DCX might be constantly
phosphorylated and dephosphorylated in COS7 cells. To explore
DCX phosphorylation under more physiological conditions, we
employed rat hippocampal young neurons that expressed DCX.
DCX is thought to play a critical role in neuronal migration by
regulating microtubules downstream of Reelin, which also acts
upstream of Rho [11]. CLA enhanced phosphorylation of
endogenous DCX, and Y-27632 inhibited CLA-induced phos-
phorylation (Figure 5C), suggesting that Rho-kinase can phos-
phorylate DCX in neurons. Nevertheless, we cannot exclude the
possibility of the off-target effects of Y-27632 on other kinases,
including PKN.
Figure 4. Identification of phosphorylation sites of DCX by Rho-kinase. (A) Schematic representation of the domain structures and deletion
mutants of DCX. Sites phosphorylated by MARK, PKA and Cdk5 are also shown. (B) Phosphorylation of DCX deletion mutants. The indicated GST-DCX
fragments were phosphorylated by GST-Rho-kinase-cat or GST-PKN-cat. The phosphorylated proteins were imaged by autoradiography. Open
arrowheads and arrows indicate the positions of substrates and autophosphorylation of kinases, respectively. These results are representatives ofa t
least three independent experiments. (C) Sequence of and potential phosphorylation sites within the 1–67 aa region. The major phosphorylation site
was identified as Thr42 (red). (D) Phosphorylation of DCX mutants with amino acid substitutions. GST-DCX-WT, -T40A, -T42A or -T40A/T42A was
incubated with Rho-kinase-cat and 50 mM[ c-
32P] ATP for 10 min at 30uC. The reaction mixtures were subjected to SDS-PAGE and GST-fused proteins
were visualized by silver staining (right). Phosphorylated proteins were imaged by autoradiography (left). Arrowhead and arrow indicate the positions
of substrates and autophosphorylation of kinase, respectively. These results are representatives of at least three independent experiments.
doi:10.1371/journal.pone.0008704.g004
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on microtubule organization in HeLa cells
Phosphorylation of DCX by Cdk5 or PKA decreases the ability
of DCX to bind to microtubules [9,10]. To examine the effects of
phosphorylation of DCX at the Rho-kinase site, DCX mutants
with a substitution at the phosphorylation site were expressed in
HeLa cells (Figure S2). GFP was diffusely distributed in HeLa cells
(Figure 6A, a). GFP-tagged DCX-WT and the -T42A mutant
were localized to microtubules (Figure 6A, d and g) and caused
highly bundled microtubules in a certain population of cells
(Figure 6A, e and h, and 6B), whereas GFP-DCX-T42E, a
phospho-mimicking form, was still localized to the microtubules
(Figure 6A, j), but lost its ability to bundle microtubules (Figure 6A,
k, and 6B), suggesting that phosphorylation of DCX at Thr-42
weakens its microtubule-bundling activity.
Discussion
In this study, we found that combining affinity column
chromatography using the catalytic domain of Rho-kinase and
shotgun LC-MS/MS analysis is powerful for identification of
substrates, including known substrates and novel ones, such as
DCX, APP and AP180. We also found that Rho-kinase
phosphorylates DCX not only in vitro, but also in vivo. Thus,
compared to previous methods, our method can easily enrich
substrates for specific kinases and can be applied for screening
other weak enzyme-substrate interactions. One of the advantages
of this method is the ability to screen protein kinase substrates,
including transmembrane proteins, in their native states. However,
it lacks information concerning direct phosphorylation, phosphor-
ylation sites, or in vivo phosphorylation. Combining this simple
method with a conventional method, such as 2D-DIGE, would be
more informative and powerful for screening novel substrates of
specific kinases and would increase understanding of the
phosphorylation network.
We employed Rho-kinase and PKN as model kinases, both of
which belong to the Rho effector and AGC families with similar
kinase domains. Nevertheless, Rho-kinase-cat-interacting proteins
were quite different from those of PKN-cat (Figure 1C, D,
Supplementary Table S1), suggesting that the proteins obtained by
affinity column chromatography bind specifically to the respective
catalytic domains. Among the known substrates, MYPT1 was
detected in eluates off the Rho-kinase-cat affinity column with
much higher scores than off the PKN-cat affinity column. AP180
and APP were enriched in the Rho-kinase-cat affinity column.
MAP2, Tau and CRMP-2, as well as DCX, were detected in both
columns, but the scores in the Rho-kinase-cat affinity column were
lower than those in the PKN-cat affinity column. Tau is
phosphorylated by PKN [13] as well as by Rho-kinase [14]. We
confirmed that CRMP-2 and DCX were efficiently phosphory-
lated by PKN in vitro. It can be speculated that the binding
affinities to the catalytic domain might reflect the phosphorylation
efficiency. Of note, when we used GSK3b, which belongs to the
CMGC kinase family with a kinase domain distinct from that of
the AGC family, as a bait, the apparent pattern of proteins off the
GSK3b affinity column on a SDS-PAGE gel is completely
different than that using Rho-kinase (data not shown).
We also found that more CRMP-2 was found in the 50 mM
NaCl eluate from the Rho-kinase-cat column than in the 1 M
NaCl eluate. AP180 was also detected in 50 mM NaCl eluates,
whereas DCX was not. Because kinase-substrate interaction is
predicted to be weak and the dissociation is faster, analysis of
eluates with low ionic strength would be also informative.
Figure 5. Phosphorylation of DCX in vivo. (A) Specificity of the
antibody against DCX phosphorylated at Thr-42 (anti-pT42 Ab). One
pmol of GST-DCX containing the indicated amounts of phosphorylated
GST-DCX-WT or -T42A was subjected to SDS-PAGE, followed by
immunoblot analysis with anti-pT42 Ab (upper panel) or anti-GST Ab
(lower panel). (B) Phosphorylation of DCX in COS7 cells. GFP-DCX was
transiently expressed into COS7 cells. The transfected cells were treated
with DMSO or 20 mM Y-27632 for 15 min, and then treated with or
without 0.1 mM calyculin A for 10 min. The cell lysates were analyzed by
immunoblot analysis with anti-pT42 Ab (upper panel) or anti-GFP Ab
(lower panel). These results are representatives of at least three
independent experiments. (C) Phosphorylation of DCX in hippocampal
neurons at DIV1. The cells were treated with DMSO or 20 mM Y-27632
for 20 min, and then treated with or without 50 nM calyculin A for
7 min. The cell lysates were analyzed by immunoblot analysis with anti-
pT42 Ab or anti-DCX Ab. Phosphorylation of MYPT1 was also examined
with anti-MYPT1 pT853 Ab. These results are representatives of at least
three independent experiments.
doi:10.1371/journal.pone.0008704.g005
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PLoS ONE | www.plosone.org 6 January 2010 | Volume 5 | Issue 1 | e8704Figure 6. Effect of mutations of DCX at phosphorylation sites on microtubule organization in HeLa cells. (A) Effect of overexpression of
DCX-WT, -T42A and -T42E in HeLa cells. DCX mutants with substitutions at phosphorylation sites were expressed in HeLa cells. HeLa cells expressing
GFP-DCX or its mutants were fixed in methanol for 10 min at room temperature. After washing, the cells were immunostained with anti-GFP and anti-
tubulin Abs. Colors indicate GFP (green) and tubulin (red). These results are representatives of at least three independent experiments. Scale bar,
10 mm. (B) The percentages of cells with highly bundled microtubules. Data are means 6 SD of three independent experiments. Asterisks indicate
that there is a significant difference from the value of control cells (p,0.05).
doi:10.1371/journal.pone.0008704.g006
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Rho-kinase-cat-interacting proteins, including both known and
newly identified substrates, suggesting that catalytic activity of
protein kinases is not essential for kinase-substrate interaction.
Nonetheless, it is noteworthy that several proteins, such as nNOS
and brain spectrin, specifically associated with Rho-kinase-cat, but
not with Rho-kinase-cat-KD; thus, the interaction of Rho-kinase-
cat with a certain group of proteins may be activity-dependent.
The other possibility is that the latter group associates with Rho-
kinase-cat only through the active center, whereas the group
interacting with both Rho-kinase-cat and -cat-KD associates with
Rho-kinase-cat at multiple sites.
The necessity of ATP for the binding to substrates is dependent
on kinases. Kinetic analyses of protein kinase revealed that there
are two kinetic mechanisms to form a ternary complex of kinase,
substrate, and ATP: a random sequential binding mechanism and
an ordered sequential binding mechanism. Rho-kinase has been
shown to bind randomly to ATP and substrates, whereas certain
types of kinase such as protein kinase A have been reported to bind
ATP first [15,16]. Actually, we confirmed that apparent bands on
SDS PAGE in eluate off Rho-kinase-cat affinity column and
interaction of AP180 with Rho-kinase-cat were not increased in
the presence of ATP (data not shown). However, ATP would be
necessary to add to the column for kinases which show an ordered
sequential binding with ATP first. Further analysis is underway to
optimize the conditions and to understand the relationship
between binding properties and phosphorylation efficiency.
Materials and Methods
Materials and chemicals
A rabbit polyclonal antibody against DCX phosphorylated at
Thr-42 (anti-pT42 Ab) was produced against the phosphopeptide
Cys-Phe
37-Tyr-Arg-Thr-Arg-phosphoThr
42-Leu-Gln-Ala-Leu-
Ser
47 by Biologica Co. (Osaka, Japan). GST, GST-Rho-kinase-cat
(6–553 amino acids), GST-Rho-kinase-cat-KD (Lys121, which is
essential for ATP-binding, is replaced by Gly), and GST-PKN-cat
(581–942 amino acids) were produced in Sf9 cells with a
baculovirus system and purified on a glutathione-sepharose
column [17]. The cDNAs encoding DCX were kindly provided
by Dr. Nakagawa (University of California). Trypsin for mass
spectrometry was purchased from Promega Co (Madison, WI).
Cy2- or Cy3-conjugated secondary antibodies against mouse or
rabbit immunoglobulin G were purchased from Jackson Immu-
noResearch Laboratories (West Grove, PA, USA). Other materials
and chemicals were obtained from commercial sources.
Plasmid construction
Human DCX (full length), DCX-N1 (1–67 aa), DCX-N2 (67–
165 aa), DCX-C1 (160–278 aa) and DCX-N2 (274–365 aa) were
amplified by the polymerase chain reaction (PCR) and subcloned
into the pGEX-2T (GE Healthcare, Princeton, NJ, USA) and/or
pEGFP-C1 (Clontech Laboratories, Mountain View, CA, USA)
plasmids. The cDNAs of human DCX-T14A, DCX-S15A, DCX-
S21A, DCX-T40A, DCX-T42A, DCX-S47A and DCX-T40A/
T42A, in which Ala is substituted for Thr-14, Ser-15, Ser-21, Thr-
40, Thr-42, Ser-47 and Thr-40/Thr-42, were generated by site-
directed mutagenesis and subcloned into the pGEX-2T and/or
pEGFP-C1 plasmids. GST-fusion proteins were produced in E.coli
and purified on a glutathione-sepharose column.
Affinity column chromatography
The affinity chromatography was performed essentially as
previously described [18,19]. The P5–7 rat brain cytosol fraction
or the P2 fraction prepared by ammonium sulfate precipitation (0–
80%) was loaded onto a 250 ml-glutathione-sepharose affinity
column, on which 5 nmol of GST, GST-Rho-kinase-cat, GST-
Rho-kinase-cat-KD or GST-PKN-cat was immobilized. After
washing the columns three times with 850 ml of buffer A (20 mM
Tris/HCl, pH 7.5, 1 mM EDTA, 1 mM DTT) and three times
with 850 ml of buffer A containing 50 mM NaCl, the bound
proteins were subsequently eluted three times with 850 ml of buffer
A containing 1 M NaCl and three times with 850 ml of buffer A
containing 10 mM glutathione. The first eluate was evaluated by
SDS-PAGE, and proteins were detected by silver staining.
Mass spectrometry
The proteins in the eluate were digested by trypsin for 16 h at
37uC after reduction, alkylation, demineralization, and concen-
tration. Nanoelectrospray tandem mass analysis was performed
using a Finnigan LTQ/Orbitrap mass spectrometry (Thermo-
Fisher Scientific Inc., Waltham, MA) system combined with a
MAGIC2002 HPLC System (Michrom BioResources Inc.,
Auburn, CA). Samples were injected onto the MAGIC2002
HPLC System equipped with a MonoCap column 0.1 mm in
diameter and 50 mm in length (AMR Inc., Tokyo Japan).
Reversed-phase chromatography was performed with a linear
gradient (0 min, 5% B; 45min, 100% B) of solvent A (2%
acetonitrile with 0.1% trifluoroacetic acid) and solvent B (98%
acetonitrile with 0.1% trifluoroacetic acid) at an estimated flow
rate of 500 nl/min. The mass spectrometer was equipped with a
XYZ interface (AMR Inc., Tokyo, Japan). Ionization was
performed by a PicoTip, 20 mm in diameter (New Objective
Inc., Woburn, MA) with a capillary voltage at 2.5 kV and
temperature of 200uC. A precursor ion scan was carried out using
a 250–4500 mass to charge ratio (m/z) prior to MS/MS analysis.
Multiple MS/MS spectra were submitted to the program Mascot
(Matrix Science Inc., Boston, MA) for the MS/MS ion search.
Phosphorylation
The phosphorylation assay was performed as previously
described [18]. In brief, the kinase reactions of Rho-kinase on
the APP cytoplasmic peptide (40 mM), GST-AP180 (1 mM), GST-
DCX (1 mM) and GST-DCX fragments (1 mM) were carried out
in 50 ml of a reaction mixture (50 mM Tris/HCl, pH 7.5, 1 mM
EDTA, 1 mM EGTA, 1 mM DTT, 5 mM MgCl2, 100 mM
[c-
32P] ATP [1 to 20 GBq/mmol]), 0.1 mM purified GST-Rho-
kinase-cat or GST-PKN-cat, and substrates for 1 h at 30uC. Then,
the reaction mixtures were spotted onto p81 paper for APP
cytoplasmic peptide, or boiled in SDS sample buffer and subjected
to SDS-PAGE for GST-fusion proteins.
The kinase reactions of Rho-kinase on the GST-DCX A
mutants were carried out in 100 ml of a reaction mixture (50 mM
Tris/HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM DTT,
5 mM MgCl2,5 0mM[ c-
32P] ATP [1 to 20 GBq/mmol]), 0.1 mM
purified GST-Rho-kinase-cat, and purified GST-DCX A mutants
(0.1 mM) for 10 min at 30uC. Then, the reaction mixtures were
boiled in SDS sample buffer and subjected to SDS-PAGE. The
radiolabeled peptide or proteins were analyzed by scintillation
counting or by an image analyzer (BAS1500; Fuji, Tokyo, Japan).
Cell culture and immunoblot analysis
COS7 cells were seeded on a 6-well dish at a density of 1.5610
5
cells/well in Dulbecco’s modified Eagle medium (DMEM) with
10% fetal bovine serum (FBS) at 37uC in an air/5% CO2
atmosphere at constant humidity. Transfections were carried out
using the Lipofectamine reagent (Invitrogen) according to the
manufacturer’s protocol. Cells were grown in DMEM with 10%
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previously described [20]. In brief, 8610
5 neurons were seeded on
a 35-mm plastic dish coated with poly-D-lysine and laminin, and
cultured for one day. Cells were treated with dimethyl sulfoxide
(DMSO) or Y-27632, and then treated with or without calyculin
A. The cells were collected with SDS sample buffer and subjected
to SDS-PAGE and immunoblot analysis using an anti-GFP Ab, an
anti-DCX Ab or an anti-pT42 Ab.
Cell culture and immunostaining
HeLa Cells were seeded on a 13-mm glass coverslip coated with
poly-D-lysine at a density of 5610
3 in DMEM with 10% FBS and
cultured overnight at 37uC in an air/5% CO2 atmosphere at
constant humidity. Transfections were carried out using the
Lipofectamine reagent (Invitrogen), according to the manufactur-
er’s protocol. Cells were grown in DMEM with 10% FBS for one
day. Cells were fixed with methanol for 10 min at room
temperature. Cells were washed with PBS at room temperature.
Cells were then incubated with anti-GFP and anti-a-tubulin
antibodies for 60 min at room temperature. After washing, the
samples were incubated with a Cy3- or Cy2-conjugated secondary
antibody. Fluorescence was examined using a Zeiss LSM 5
PASCAL laser confocal microscope (Carl Zeiss, Obeokochem,
Germany).
Supporting Information
Figure S1 Detection of CRMP-2 (DPYL2) in Rho-kinase-cat-
interacting proteins. Eluates off affinity columns with 50 mM and
1 M NaCl were subjected to immunoblot analysis with anti-
CRMP-2 Ab. CRMP-2 was strongly detected in eluates off the
PKN-cat column, and moderately off the Rho-kinase-cat column.
Middle panel is a longer exposure of the same blot shown in upper
panel.
Found at: doi:10.1371/journal.pone.0008704.s001 (0.50 MB TIF)
Figure S2 Expression of GFP-DCX in HeLa cells. HeLa cell
lysate expressing GFP, GFP-DCX-WT, or GFP-DCX mutants
was subjected to immunoblot analysis with anti-GFP Ab. The
expression levels of GFP-DCX mutants were almost same as that
of GFP-DCX-WT.
Found at: doi:10.1371/journal.pone.0008704.s002 (0.25 MB TIF)
Table S1 Representative list of kinase-interacting proteins
detected by affinity column chromatography and LC-MS/MS
analysis.
Found at: doi:10.1371/journal.pone.0008704.s003 (0.24 MB
XLS)
Acknowledgments
We thank Dr. M. Nakagawa (University of California) and Dr. T. Suzuki
(Hokkaido University) for kindly providing DCX cDNA and the APP
cytoplasmic peptide, respectively. We thank Mr. Y. Yamakawa (Division
for Medical Research Engineering, Nagoya University), ThermoFisher
Scientific Inc. and AMR Inc. for mass spectrometric analysis. We also
thank Ms. Y. Kanazawa for technical assistance and Ms. T. Ishii for
secretarial assistance.
Author Contributions
Conceived and designed the experiments: MA KK. Performed the
experiments: MA YT KT HH KM TN KK TS YN AI. Analyzed the
data: MA YT KT HH AI. Contributed reagents/materials/analysis tools:
MA YT KT HH KM TN KK TS YN. Wrote the paper: MA.
References
1. Ptacek J, Devgan G, Michaud G, Zhu H, Zhu X, et al. (2005) Global analysis of
protein phosphorylation in yeast. Nature 438: 679–684.
2. Schmelzle K, White FM (2006) Phosphoproteomic approaches to elucidate
cellular signaling networks. Curr Opin Biotechnol 17: 406–414.
3. Tedford NC, Hall AB, Graham JR, Murphy CE, Gordon NF, et al. (2009)
Quantitative analysis of cell signaling and drug action via mass spectrometry-
based systems level phosphoproteomics. Proteomics 9: 1469–1487.
4. Machida M, Kosako H, Shirakabe K, Kobayashi M, Ushiyama M, et al. (2007)
Purification of phosphoproteins by immobilized metal affinity chromatography
and its application to phosphoproteome analysis. Febs J 274: 1576–1587.
5. Ubersax JA, Ferrell JE, Jr. (2007) Mechanisms of specificity in protein
phosphorylation. Nat Rev Mol Cell Biol 8: 530–541.
6. Biondi RM, Nebreda AR (2003) Signalling specificity of Ser/Thr protein kinases
through docking-site-mediated interactions. Biochem J 372: 1–13.
7. Kaibuchi K, Kuroda S, Amano M (1999) Regulation of the cytoskeleton and cell
adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem
68: 459–486.
8. Riento K, Ridley AJ (2003) Rocks: multifunctional kinases in cell behaviour. Nat
Rev Mol Cell Biol 4: 446–456.
9. Tanaka T, Serneo FF, Tseng HC, Kulkarni AB, Tsai LH, et al. (2004) Cdk5
phosphorylation of doublecortin ser297 regulates its effect on neuronal
migration. Neuron 41: 215–227.
10. Schaar BT, Kinoshita K, McConnell SK (2004) Doublecortin microtubule
affinity is regulated by a balance of kinase and phosphatase activity at the leading
edge of migrating neurons. Neuron 41: 203–213.
11. Kawauchi T, Hoshino M (2008) Molecular pathways regulating cytoskeletal
organization and morphological changes in migrating neurons. Dev Neurosci
30: 36–46.
12. Inada H, Togashi H, Nakamura Y, Kaibuchi K, Nagata K, et al. (1999) Balance
between activities of Rho kinase and type 1 protein phosphatase modulates
turnover of phosphorylation and dynamics of desmin/vimentin filaments. J Biol
Chem 274: 34932–34939.
13. Taniguchi T, Kawamata T, Mukai H, Hasegawa H, Isagawa T, et al. (2001)
Phosphorylation of tau is regulated by PKN. J Biol Chem 276: 10025–10031.
14. Amano M, Kaneko T, Maeda A, Nakayama M, Ito M, et al. (2003)
Identification of Tau and MAP2 as novel substrates of Rho-kinase and myosin
phosphatase. J Neurochem 87: 780–790.
15. Trauger JW, Lin FF, Turner MS, Stephens J, LoGrasso PV (2002) Kinetic
mechanism for human Rho-Kinase II (ROCK-II). Biochemistry 41: 8948–8953.
16. Futer O, Saadat AR, Doran JD, Raybuck SA, Pazhanisamy S (2006) Phosphoryl
transfer is not rate-limiting for the ROCK I-catalyzed kinase reaction.
Biochemistry 45: 7913–7923.
17. Amano M, Chihara K, Nakamura N, Kaneko T, Matsuura Y, et al. (1999) The
COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J Biol
Chem 274: 32418–32424.
18. Amano M, Mukai H, Ono Y, Chihara K, Matsui T, et al. (1996) Identification
of a putative target for Rho as the serine-threonine kinase protein kinase N.
Science 271: 648–650.
19. Hikita T, Taya S, Fujino Y, Taneichi-Kuroda S, Ohta K, et al. (2009) Proteomic
analysis reveals novel binding partners of dysbindin, a schizophrenia-related
protein. J Neurochem.
20. Arimura N, Kimura T, Nakamuta S, Taya S, Funahashi Y, et al. (2009)
Anterograde transport of TrkB in axons is mediated by direct interaction with
Slp1 and Rab27. Dev Cell 16: 675–686.
Screening of Kinase Substrates
PLoS ONE | www.plosone.org 9 January 2010 | Volume 5 | Issue 1 | e8704